NCT04717765 - Photobiomodulation in Oral Lesions Resulting From Anti-neoplastic Prevention | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 10, 2021

Primary Completion Date

February 28, 2023

Study Completion Date

August 31, 2023

Conditions

Oral MucositisOsteoradionecrosisOsteonecroses, BisphosphonateOsteonecrosis Due to Drugs, JawHyposalivationHead and Neck CancerOral Cancer

Interventions

DEVICE

Preventive, LLL Phototherapy and topical Vit E

Interventions will be carried out for patients who have already passed or will undergo anti-neoplastic chemotherapy or radiation therapy.

DEVICE

Curative, LLL Phototherapy and topical Vit E

Interventions will be carried out for patients who have already passed or will undergo anti-neoplastic chemotherapy or radiation therapy.

DEVICE

Preventive, LLL Phototherapy and LPRF

Interventions will be carried out for patients who have already passed or will undergo anti-neoplastic chemotherapy or radiation therapy.

DEVICE

Curative, LLL Phototherapy and LPRF

Interventions will be carried out for patients who have already passed or will undergo anti-neoplastic chemotherapy or radiation therapy.

Trial Locations (1)

Hospital Clinico Universitário, Santiago de Compostela

All Listed Sponsors

lead

University of Santiago de Compostela

OTHER